MedTrace Logo

Evaluation of the Omnipod DASH in Children and Adolescents With Type 1 Diabetes Mellitus

NCT05377385 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2022-09-23

No results posted yet for this study

Summary

In this study the usability of the Omnipod DASH insulin administration system is evaluated prospectively by two questionnaires. The effect on the metabolic control is evaluated retrospectively by analysis of data from the medical records of the patients.

Conditions

  • Diabetes Mellitus, Type 1
  • Children
  • Metabolic Control
  • Patient Satisfaction

Interventions

BEHAVIORAL

Questionnaire

Questionnaire about usability of the Omnipod DASH insulin administration system

Sponsors & Collaborators

  • Jessa Hospital

    lead OTHER

Principal Investigators

  • Guy Massa · Jessa Hospital

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-13
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377385 on ClinicalTrials.gov